The Oxford-AstraZeneca Covid-19 vaccine, which is in the final phase of the human trials in India, will be ready for use in December itself in the country if the government decides to go for 'emergency use authorisation', reports Times of India.
According to the report, in case the government decides against emergency authorisation of the vaccine, it could still be launched in January as the third-stage trials are likely to be over by December.
Pune-based Serum Institute of India, which is the world's largest vaccine maker in terms of doses produced, has partnered with British-Swedish pharma company AstraZeneca for the production of the Covid-19 vaccine.
Around 100 million doses of the vaccine could be made widely available by the second quarter of 2021, Serum Institute's CEO Adar Poonawalla told a private news channel on Wednesday (28 October).
“If we don’t go for an emergency licence, our trials should be over by December and then we can maybe launch in India in January subject to the UK trial also being completed which it’s on the verge of being completed,” Poonawalla was quoted as saying.
The Serum CEO further said that if the vaccine is found safe by the UK authorities, the company could reach out to Indian regulator for a possible emergency license for the vaccine in December.
He further said that the company is aiming for 100 million doses of the vaccine at first, that would be available by as early as the second quarter of 2021.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.